Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
OTHERS FINTEC GLOBAL BERHAD ["FINTEC" or "the Company"]
- ANNOUNCEMENT PURSUANT TO RULE 9.20 OF THE ACE MARKET LISTING REQUIREMENTS
FINTEC GLOBAL BERHAD
Type
Announcement
Subject
OTHERS
Description
FINTEC GLOBAL BERHAD ["FINTEC" or "the Company"]
- ANNOUNCEMENT PURSUANT TO RULE 9.20 OF THE ACE MARKET LISTING REQUIREMENTS
Pursuant to Rule 9.20 of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, FINTEC GLOBAL BERHAD ("FINTEC" or "the Company") wishes to announce that as at 17 July 2026, the aggregate value of quoted securities acquired by Asiabio Capital Sdn. Bhd. and Fintec Global Limited, the wholly-owned subsidiaries of the Company, that are principally involved in the investment in marketable securities, that has not been announced for the preceding twelve (12) months has exceeded 5% of FINTEC's latest audited consolidated net assets as at 30 June 2025. The details of the investment in the quoted securities are as follows:-
RM
% of FINTEC's latest audited consolidated net assets
a.
Aggregate purchase consideration within the preceding twelve (12) months
7,574,592.23
5.14
b.
Aggregate sale consideration within the preceding twelve (12) months
-
-
RM
c.
Investments in quoted securities as at 17 July 2026
- Total Cost
218,133,954.14
- Total Book Value
52,946,531.65
- Total Market Value
50,250,976.56
d.
Net Loss arising from the disposal of quoted securities by FINTEC Group during the current financial year ending 30 June 2026 (Sales proceeds less investment cost and incidental expenses)
-
The acquisition of the quoted securities as announced were made within the period from 1 December 2025 to 16 July 2026.